Human papillomavirus test with cytology triage in organized screening for cervical cancer

The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples

(2016) Renée M.F. Ebisch et al.   INTERNATIONAL JOURNAL OF CANCER

Triage of HPV positive women in cervical cancer screening

(2016) Nicolas Wentzensen et al.   JOURNAL OF CLINICAL VIROLOGY

Use of Cytology, E6/E7 mRNA, and p16INK4a–Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening

(2015) Daniela Gustinucci et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

(2015) M. Arbyn et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial

(2015) Joseph Monsonego et al.   GYNECOLOGIC ONCOLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial

(2014) Viola M J Verhoef et al.   LANCET ONCOLOGY

The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland

(2013) Heini Salo et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

(2013) A. T. Hesselink et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

(2012) Debbie Saslow et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

(2011) Dorien C. Rijkaart et al.   INTERNATIONAL JOURNAL OF CANCER

Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting

(2011) F. M. Carozzi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening

(2011) M. Poljak et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

(2009) Henry C Kitchener et al.   LANCET ONCOLOGY